UK Cancer death rate increases 17% since Covid-19 pandemic
According to an article published in the journal Lancet Oncology, cancer death rates in the UK have increased by 17% since the Covid-19 pandemic.
The UK's National Health Service (NHS) has warned that the UK is in the midst of a major healthcare crisis as months-long cancer treatment delays become increasingly common, leading to higher mortality.
On December 14, a number of British media cited recent NHS figures showing that nearly 40% of cancer patients, who were urgently referred by their family doctors to specialized treatment facilities in October, had to wait an additional two months before receiving treatment.
According to doctors, delaying of just 4 weeks in cancer treatment increases mortality by 6% to 13% for solid tumors, and this rate increases further if delayed. Meanwhile, according to an article published in the journal Lancet Oncology, the UK cancer death rate has increased by 17% due to delays in diagnosis and treatment since the Covid-19 pandemic. This is believed to have contributed significantly to the disruption of cancer treatments in the country.
Clinicians from Imperial College London, the Institute of Cancer Policy at King's College, Radiotherapy UK and Check4Cancer have called for immediate action to tackle the medical crisis.
UK Cancer death rate increases 17% since Covid-19 pandemic
Eye drops caused many Americans have to cut off eyeballs
Eye drops have been an essential medication for years to aid in eye redness, swelling, and visual disturbance. However, a drug-resistant bacterial infection found in eye drops has led to serious injury and even the death of one person.
Eye drops have been an essential medication for years to aid in eye redness, swelling, and visual disturbance. However, a drug-resistant bacterial infection found in eye drops has led to serious injury and even the death of one person.
Read more
AstraZeneca’s Drug proves effective in extending the Lifespan of Lung Cancer patients
On March 9, British-Swedish pharmaceutical company AstraZeneca announced that its cancer drug Imfinzi has proven to be effective in increasing the survival time of lung cancer patients. The drug, which is a form of immunotherapy, was able to significantly extend the lifespan of patients suffering from early-stage non-small cell lung cancer.
On March 9, British-Swedish pharmaceutical company AstraZeneca announced that its cancer drug Imfinzi has proven to be effective in increasing the survival time of lung cancer patients. The drug, which is a form of immunotherapy, was able to significantly extend the lifespan of patients suffering from early-stage non-small cell lung cancer.
Read more
Hong Kong could ‘import’ up to 7,000 Nurses next year
The Hong Kong government said on December 15 that the region could import up to 7,000 nurses for positions at Hong Kong's nursing homes to care for the elderly.
The Hong Kong government said on December 15 that the region could import up to 7,000 nurses for positions at Hong Kong\'s nursing homes to care for the elderly.
Read more
US approves New metastatic Lung Cancer medicine
The US Food and Drug Administration (FDA) has approved the new cancer treatment medicine adagrasib for patients with end-stage lung cancer.
The US Food and Drug Administration (FDA) has approved the new cancer treatment medicine adagrasib for patients with end-stage lung cancer.
Read more
First Vaccine prolongs Brain Cancer survival
Scientists at King's College Hospital have developed the world's first vaccine that can treat malignant brain tumours to help patients live for many years.
Scientists at King\'s College Hospital have developed the world\'s first vaccine that can treat malignant brain tumours to help patients live for many years.
Read more
A RARE CASE OF MONKEYPOX VIRUS INFECTION HAS BEEN DETECTED IN THE UK
A rare case of monkeypox virus infection has been detected in the UK, the UK Health Security Agency (UKHSA) said on May 7.
A rare case of monkeypox virus infection has been detected in the UK, the UK Health Security Agency (UKHSA) said on May 7.
Read more
Digital Health Is On The Race
Digital health has nearly doubled by 2021 to $57 billion.
Digital health has nearly doubled by 2021 to $57 billion.
Read more